418 related articles for article (PubMed ID: 34294128)
1. Metabolic landscapes in sarcomas.
Miallot R; Galland F; Millet V; Blay JY; Naquet P
J Hematol Oncol; 2021 Jul; 14(1):114. PubMed ID: 34294128
[TBL] [Abstract][Full Text] [Related]
2. On the Relevance of Soft Tissue Sarcomas Metabolic Landscape Mapping.
Esperança-Martins M; F Duarte I; Rodrigues M; Soares do Brito J; López-Presa D; Costa L; Fernandes I; Dias S
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232732
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-mediated gene regulations in human sarcomas.
Subramanian S; Kartha RV
Cell Mol Life Sci; 2012 Nov; 69(21):3571-85. PubMed ID: 22922987
[TBL] [Abstract][Full Text] [Related]
4. Metabolite sensing and signaling in cancer.
Wang YP; Li JT; Qu J; Yin M; Lei QY
J Biol Chem; 2020 Aug; 295(33):11938-11946. PubMed ID: 32641495
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic profiling from formalin-fixed, paraffin-embedded tumor tissue using targeted LC/MS/MS: application in sarcoma.
Kelly AD; Breitkopf SB; Yuan M; Goldsmith J; Spentzos D; Asara JM
PLoS One; 2011; 6(10):e25357. PubMed ID: 21984915
[TBL] [Abstract][Full Text] [Related]
6. Sarcoma Metabolomics: Current Horizons and Future Perspectives.
Esperança-Martins M; Fernandes I; Soares do Brito J; Macedo D; Vasques H; Serafim T; Costa L; Dias S
Cells; 2021 Jun; 10(6):. PubMed ID: 34201149
[TBL] [Abstract][Full Text] [Related]
7. Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancers.
Yu TJ; Ma D; Liu YY; Xiao Y; Gong Y; Jiang YZ; Shao ZM; Hu X; Di GH
Mol Ther; 2021 Jul; 29(7):2350-2365. PubMed ID: 33677091
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms underpinning sarcomas and implications for current and future therapy.
Damerell V; Pepper MS; Prince S
Signal Transduct Target Ther; 2021 Jun; 6(1):246. PubMed ID: 34188019
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry Imaging.
Lou S; Balluff B; Cleven AHG; Bovée JVMG; McDonnell LA
J Am Soc Mass Spectrom; 2017 Feb; 28(2):376-383. PubMed ID: 27873216
[TBL] [Abstract][Full Text] [Related]
10. Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells.
Hettmer S; Liu J; Miller CM; Lindsay MC; Sparks CA; Guertin DA; Bronson RT; Langenau DM; Wagers AJ
Proc Natl Acad Sci U S A; 2011 Dec; 108(50):20002-7. PubMed ID: 22135462
[TBL] [Abstract][Full Text] [Related]
11. Sarcoma microenvironment cell states and ecosystems are associated with prognosis and predict response to immunotherapy.
Subramanian A; Nemat-Gorgani N; Ellis-Caleo TJ; van IJzendoorn DGP; Sears TJ; Somani A; Luca BA; Zhou MY; Bradic M; Torres IA; Oladipo E; New C; Kenney DE; Avedian RS; Steffner RJ; Binkley MS; Mohler DG; Tap WD; D'Angelo SP; van de Rijn M; Ganjoo KN; Bui NQ; Charville GW; Newman AM; Moding EJ
Nat Cancer; 2024 Apr; 5(4):642-658. PubMed ID: 38429415
[TBL] [Abstract][Full Text] [Related]
12. The spectrum and significance of secondary (co-occurring) genetic alterations in sarcomas: the hallmarks of sarcomagenesis.
Dermawan JK; Rubin BP
J Pathol; 2023 Aug; 260(5):637-648. PubMed ID: 37345731
[TBL] [Abstract][Full Text] [Related]
13. Metabolic profiling of cancer cells reveals genome-wide crosstalk between transcriptional regulators and metabolism.
Ortmayr K; Dubuis S; Zampieri M
Nat Commun; 2019 Apr; 10(1):1841. PubMed ID: 31015463
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory stress and sarcomagenesis: a vicious interplay.
Radons J
Cell Stress Chaperones; 2014 Jan; 19(1):1-13. PubMed ID: 24046208
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas.
Suehara Y; Kohsaka S; Yamaguchi S; Hayashi T; Kurihara T; Sano K; Sasa K; Akaike K; Ueno T; Kojima S; Ikegami M; Mizuno S; Okubo T; Kim Y; Kaneko K; Saito T; Kato S; Mano H
Clin Orthop Relat Res; 2020 Nov; 478(11):2461-2476. PubMed ID: 32567826
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathology of sarcomas.
Osuna D; de Alava E
Rev Recent Clin Trials; 2009 Jan; 4(1):12-26. PubMed ID: 19149759
[TBL] [Abstract][Full Text] [Related]
17. NTRK3 overexpression in undifferentiated sarcomas with YWHAE and BCOR genetic alterations.
Kao YC; Sung YS; Argani P; Swanson D; Alaggio R; Tap W; Wexler L; Dickson BC; Antonescu CR
Mod Pathol; 2020 Jul; 33(7):1341-1349. PubMed ID: 32034283
[TBL] [Abstract][Full Text] [Related]
18. CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets.
Kohlmeyer JL; Gordon DJ; Tanas MR; Monga V; Dodd RD; Quelle DE
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344731
[TBL] [Abstract][Full Text] [Related]
19. Identification, by systematic RNA sequencing, of novel candidate biomarkers and therapeutic targets in human soft tissue tumors.
Sarver AE; Sarver AL; Thayanithy V; Subramanian S
Lab Invest; 2015 Sep; 95(9):1077-88. PubMed ID: 26121316
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
